These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 34192561)
1. Downregulation of DNMT3a expression by RNAi and its effect on NF-κBs expression of thymic epithelial cells. Meng FJ; Guo F; Sun ZN; Wang SJ; Yang CR; Wang CY; Zhang WC; Gao ZY; Ji LL; Feng FK; Guan ZY; Wang GS Immunol Lett; 2021 Sep; 237():17-26. PubMed ID: 34192561 [TBL] [Abstract][Full Text] [Related]
2. Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor-kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis. Guo F; Wang CY; Wang S; Zhang J; Yan YJ; Guan ZY; Meng FJ Thorac Cancer; 2019 Mar; 10(3):564-570. PubMed ID: 30734484 [TBL] [Abstract][Full Text] [Related]
3. Infrequent and low AIRE expression in thymoma: difference in AIRE expression among WHO subtypes does not correlate with association of MG. Suzuki E; Kobayashi Y; Yano M; Fujii Y Autoimmunity; 2008 Aug; 41(5):377-82. PubMed ID: 18568643 [TBL] [Abstract][Full Text] [Related]
4. Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis. Kanatli I; Akkaya B; Uysal H; Kahraman S; Sanlioglu AD Neuromuscul Disord; 2017 Feb; 27(2):128-135. PubMed ID: 28012741 [TBL] [Abstract][Full Text] [Related]
5. Muscle nicotinic acetylcholine receptor mRNA expression in hyperplastic and neoplastic myasthenia gravis thymus. MacLennan CA; Beeson D; Willcox N; Vincent A; Newsom-Davis J Ann N Y Acad Sci; 1998 May; 841():407-10. PubMed ID: 9668266 [No Abstract] [Full Text] [Related]
6. Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour. Chang KC; Wu MH; Jones D; Chen FF; Tseng YL J Pathol; 2006 Oct; 210(2):224-33. PubMed ID: 16917804 [TBL] [Abstract][Full Text] [Related]
7. LncRNA XLOC_003810 modulates thymic Th17/Treg balance in myasthenia gravis with thymoma. Niu L; Jiang J; Yin Y; Hu B Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):989-996. PubMed ID: 32048308 [TBL] [Abstract][Full Text] [Related]
8. Gene-Specific Methylation Analysis in Thymomas of Patients with Myasthenia Gravis. Lopomo A; Ricciardi R; Maestri M; De Rosa A; Melfi F; Lucchi M; Mussi A; Coppedè F; Migliore L Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999265 [TBL] [Abstract][Full Text] [Related]
9. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes. Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A Front Immunol; 2020; 11():664. PubMed ID: 32373124 [TBL] [Abstract][Full Text] [Related]
10. Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes. Luo Z; Li Y; Liu X; Luo M; Xu L; Luo Y; Xiao B; Yang H BMC Med Genomics; 2015 Mar; 8():13. PubMed ID: 25889429 [TBL] [Abstract][Full Text] [Related]
11. Functional expression of receptors for calcitonin gene-related peptide, calcitonin, and vasoactive intestinal peptide in the human thymus and thymomas from myasthenia gravis patients. Marie J; Wakkach A; Coudray A; Chastre E; Berrih-Aknin S; Gespach C J Immunol; 1999 Feb; 162(4):2103-12. PubMed ID: 9973484 [TBL] [Abstract][Full Text] [Related]
12. Different patterns of nicotinic acetylcholine receptor subunit transcription in human thymus. Bruno R; Sabater L; Tolosa E; Sospedra M; Ferrer-Francesch X; Coll J; Foz M; Melms A; Pujol-Borrell R J Neuroimmunol; 2004 Apr; 149(1-2):147-59. PubMed ID: 15020075 [TBL] [Abstract][Full Text] [Related]
13. Genetic characterization of thymoma. Yu L; Ke J; Du X; Yu Z; Gao D Sci Rep; 2019 Feb; 9(1):2369. PubMed ID: 30787364 [TBL] [Abstract][Full Text] [Related]
14. [The level of Bcl-2 and Fas expression in thymoma tissue from patients with myasthenia gravis]. Shen G; Chai Y; Yue L; Wei HQ; Lin M Zhonghua Jie He He Hu Xi Za Zhi; 2006 Apr; 29(4):240-2. PubMed ID: 16750039 [TBL] [Abstract][Full Text] [Related]
15. LncRNA and mRNA expression associated with myasthenia gravis in patients with thymoma. Ke J; Du X; Cui J; Yu L; Li H Thorac Cancer; 2022 Jan; 13(1):15-23. PubMed ID: 34773374 [TBL] [Abstract][Full Text] [Related]
16. Autoimmune regulator expression in thymomas with or without autoimmune disease. Liu Y; Zhang H; Zhang P; Meng F; Chen Y; Wang Y; Yao Y; Qi B Immunol Lett; 2014 Sep; 161(1):50-6. PubMed ID: 24768600 [TBL] [Abstract][Full Text] [Related]
17. Different molecular expression in thymoma with ocular or generalized myasthenia gravis. Zhang M; Li H; Guo J; Zhou Y; Gong L; Wang X; Li Z; Zhang W J Neurol Sci; 2012 Feb; 313(1-2):27-31. PubMed ID: 22000402 [TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of thymoma with myasthenia gravis: Risk factors of developing myasthenia gravis in thymoma patients. Lee MC; Hsiao TH; Chuang HN; Lee LW; Chi PL; Tsai HM; Mao CL; Hsu CP Lung Cancer; 2020 Jan; 139():157-164. PubMed ID: 31809976 [TBL] [Abstract][Full Text] [Related]
19. Expression of receptor for advanced glycation end-products (RAGE) in thymus from myasthenia patients. Bouchikh M; Zouaidia F; Benhaddou EHA; Mahassini N; Achir A; El Malki HO Rev Neurol (Paris); 2017 Jun; 173(6):388-395. PubMed ID: 28461027 [TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers. Lefeuvre CM; Payet CA; Fayet OM; Maillard S; Truffault F; Bondet V; Duffy D; de Montpreville V; Ghigna MR; Fadel E; Mansuet-Lupo A; Alifano M; Validire P; Gossot D; Behin A; Eymard B; Berrih-Aknin S; Le Panse R J Autoimmun; 2020 Jan; 106():102337. PubMed ID: 31594658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]